Marchand Institute’s Paper on Retosiban Accepted for Publication in Current Medical Research and Opinion
The institute is pleased to announce that ourlatest paper, “Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban” has been accepted for Publication in Current Medical Research and Opinion. The article can be viewed online at this link, and seen on…